Chronic Kidney Disease Clinical Trials

Find Chronic Kidney Disease Clinical Trials Near You

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure - CHRONOVAX 2

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Immune response to influenza vaccine in patients with chronic renal insufficiency.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:

• Chronic renal failure patient at stage 4 or 5 (i.e. estimated GFR \< 30mL/min/1.73m2); or Dialysis patient; or renal transplant patient regardless of GFR;

• Age ≥ 18 years;

• Indication for influenza vaccination;

• Express free and informed consent.

Locations
Other Locations
France
CHU Nice - Hôpital Pasteur 2
RECRUITING
Nice
Contact Information
Primary
GOSSET Clément, MD
gosset.c@chu-nice.fr
492038632
Time Frame
Start Date: 2025-09-03
Estimated Completion Date: 2027-09
Participants
Target number of participants: 735
Treatments
Active_comparator: Morning injection
VAXIGRIPTETRA influenza vaccine injection between 07:00 am and 11:00 am.
Active_comparator: Evening injection
VAXIGRIPTETRA influenza vaccine injection between 05:00 pm and 09:00 pm.
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de Nice

This content was sourced from clinicaltrials.gov